Identification of potential biomarkers in active Lyme borreliosis
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287586 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Ivar Tjernberg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Transfusion Medicine, Region Kalmar County, Kalmar, Sweden. Hauptthemen laut MEDLINE: Lyme Disease, Borrelia, Borrelia burgdorferi. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Kalmar County (IT), Futurum-Academy for Healthcare and Division of Medical Diagnostics, Region Jönköping County, Interreg IVA Program ScandTick, Interreg V program ScandTick Innovation, The Medical Research Council of Southeast Sweden.
Abstract (Originalsprache)
Objectives
Lyme serology does not readily discriminate an active Lyme borreliosis (LB) from a previous Borrelia infection or exposure. Here, we aimed to investigate a large number of immunological protein biomarkers to search for an immunological pattern typical for active LB, in contrast to patterns found in healthy blood donors, a proportion of whom were previously exposed to Borrelia .
Methods
Serum samples from well-characterised adult patients with ongoing LB and healthy blood donors were included and investigated using a proximity extension assay (provided by Olink®) by which 92 different immune response-related human protein biomarkers were analysed simultaneously.
Results
In total, 52 LB patients and 75 healthy blood donors were included. The blood donors represented both previously Borrelia exposed (n = 34) and not exposed (n = 41) based on anti- Borrelia antibody status. Ten of the examined 92 proteins differed between patients and blood donors and were chosen for further logistic regression (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chemistry and Transfusion Medicine, Region Kalmar County, Kalmar, Sweden.
- Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.
- National Reference Laboratory for Borrelia, Department of Clinical Microbiology in Jönköping, Region Jönköping County, Linköping University, Linköping, Sweden.
- National Reference Laboratory for Borrelia, Department of Clinical Microbiology, Sørlandet Hospital Trust, Kristiansand, Norway.
- Department of Clinical Microbiology, Sørlandet Hospital Health Enterprise, Kristiansand, Norway.
- National Advisory Unit on Tick Borne Diseases, Sørlandet Hospital Trust, Kristiansand, Norway.
ORCID-Profile: Ivar Tjernberg
Förderung
- Region Kalmar County (IT), Futurum-Academy for Healthcare and Division of Medical Diagnostics, Region Jönköping County, Interreg IVA Program ScandTick
- Interreg V program ScandTick Innovation
- The Medical Research Council of Southeast Sweden
- the foundation for medical research of the Åland cultural foundation
- Wilhelm and Else Stockmann Foundation
Zitieren
APA
Tjernberg, I., Lager, M., Furset Jensen, G., Eikeland, R., Nyman, D., Brudin, L., & Henningsson, A. J. (2023). Identification of potential biomarkers in active Lyme borreliosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0287586
Vancouver
Tjernberg I, Lager M, Furset Jensen G, Eikeland R, Nyman D, Brudin L, et al. Identification of potential biomarkers in active Lyme borreliosis. PLOS ONE. 2023. doi:10.1371/journal.pone.0287586
BibTeX
@article{Tjernberg2023,
author = {Tjernberg, Ivar and Lager, Malin and Furset Jensen, Guro and Eikeland, Randi and Nyman, Dag and Brudin, Lars and Henningsson, Anna J},
title = {Identification of potential biomarkers in active Lyme borreliosis},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287586}
}
EUVIMED